Christiane Schumann

Prognostic Significance of<i>ASXL1</i>Mutations in Patients With Myelodysplastic Syndromes

Felicitas Thol, Inna Friesen, Frédérik Damm et al. · Journal of Clinical Oncology · 2011 · 275 citations · Full text

Medicine, Hematology, Molecular Genetics +17

IDH1 mutations in patients with myelodysplastic syndromes are associated with an unfavorable prognosis

Felicitas Thol, E. M. Weissinger, J. Krauter et al. · Haematologica · 2010 · 190 citations · Full text

Life Sciences, Genetics, Hematology +13

Thromboembolic events in children with acute lymphoblastic leukemia (BFM protocols): prednisone versus dexamethasone administration

Ulrike Nowak‐Göttl, E. Ahlke, Gudrun Fleischhack et al. · Blood · 2003 · 132 citations · Full text

Medicine, Oncology, Pediatrics +15

Results from a 1-year, open-label, single arm, multi-center trial evaluating the efficacy and safety of oral Deferasirox in patients diagnosed with low and int-1 risk myelodysplastic syndrome (MDS) and transfusion-dependent iron overload

Florian Nolte, Britta Höchsmann, Aristoteles Giagounidis et al. · Annals of Hematology · 2012 · 78 citations

Medicine, Pharmacology, Pharmacotherapy +16

Transcriptional down-regulation of the Wnt antagonist SFRP1 in haematopoietic cells of patients with different risk types of MDS

Jana Reins, Maximilian Mossner, Martín Neumann et al. · Leukemia Research · 2010 · 35 citations

Medicine, Hematology, Molecular Biology +17